Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A. The company is also developing ALS-2/3 for the treatment of gram+ve bacterial infections; RPIDD, a pathogen molecular diagnostic; NativusWell DOI (NLS-2), a dietary supplement; NLS-1 for the treatment of endometriosis; DLS-1+2 to treat NSCLC with mutation; DLS-3, an autoimmune small molecule; and CLS-1 for the treatment of obesity. Its pipeline products enable the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platforms for treatment of metabolic diseases. The company also focuses on therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women's health, and other disease areas. In addition, it operates a medical clinic. The company was formerly known as APTUS Holdings Limited and changed its name to Aptorum Group Limited in October 2017. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom. Aptorum Group Limited is a subsidiary of Jurchen Investment Corporation.
-3.61EPS Dil.
-1.41P/E
26.43MMarket Cap
Capital Structure
FRC
•
in mil. unless spec.
Jun'22
Dec'22
Jun'23
ST Debt
premium
Premium data
premium
Premium data
premium
Premium data
LT Borrowings
premium
Premium data
premium
Premium data
premium
Premium data
LT Finance Leases
premium
Premium data
premium
Premium data
premium
Premium data
Preferred Equity and Hybrid Capital
premium
Premium data
premium
Premium data
premium
Premium data
Shares Outstanding
premium
Premium data
premium
Premium data
premium
Premium data
Market Capitalization
premium
Premium data
premium
Premium data
premium
Premium data
Working Capital
FRC
•
in mil. unless spec.
Jun'22
Dec'22
Jun'23
Total Current Assets
premium
Premium data
premium
Premium data
premium
Premium data
Cash, Cash Equivalents & STI
premium
Premium data
premium
Premium data
premium
Premium data
Accounts Receivable, Net
premium
Premium data
premium
Premium data
premium
Premium data
Inventories
premium
Premium data
premium
Premium data
premium
Premium data
Total Current Liabilities
premium
Premium data
premium
Premium data
premium
Premium data
Payables & Accruals
premium
Premium data
premium
Premium data
premium
Premium data
ST Debt
premium
Premium data
premium
Premium data
premium
Premium data
Deferred Revenue
premium
Premium data
premium
Premium data
premium
Premium data
Quarterly Dividends Per Share
FRC
•
in mil. unless spec.
Year
Q1
Q2
Q3
Q4
FY
2021
premium
Premium data
premium
Premium data
- -
- -
premium
Premium data
2022
premium
Premium data
premium
Premium data
- -
- -
premium
Premium data
2023
premium
Premium data
- -
- -
- -
- -
Quarterly Revenue
FRC
•
in mil. unless spec.
Year
Q1
Q2
Q3
Q4
FY
2021
premium
Premium data
premium
Premium data
- -
- -
premium
Premium data
2022
premium
Premium data
premium
Premium data
- -
- -
premium
Premium data
2023
premium
Premium data
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2017
2018
2019
2020
2021
2022
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
Revenue per ShareRevenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
Basic EPS, GAAPBasic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
Free Cash Flow per Basic ShareFree Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
Dividend per ShareDividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
Book Value per ShareBook Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
Tangible Book Value per ShareTangible Book Value per Share